The estimated Net Worth of Richard Denness is at least $2.57 Milion dollars as of 1 August 2020. Mr Denness owns over 33,005 units of Option Care Health stock worth over $2,196,062 and over the last 6 years he sold OPCH stock worth over $0. In addition, he makes $376,445 as Chief Commercial Officer at Option Care Health.
Mr has made over 2 trades of the Option Care Health stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 33,005 units of OPCH stock worth $1,070,352 on 1 August 2020.
The largest trade he's ever made was exercising 33,005 units of Option Care Health stock on 1 August 2020 worth over $1,070,352. On average, Mr trades about 5,195 units every 37 days since 2018. As of 1 August 2020 he still owns at least 67,717 units of Option Care Health stock.
You can see the complete history of Mr Denness stock trades at the bottom of the page.
Richard P. Denness is the Chief Commercial Officer at Option Care Health.
As the Chief Commercial Officer of Option Care Health, the total compensation of Mr Denness at Option Care Health is $376,445. There are 9 executives at Option Care Health getting paid more, with Harriet Booker having the highest compensation of $1,393,652.
Mr Denness is 54, he's been the Chief Commercial Officer of Option Care Health since . There are 9 older and 9 younger executives at Option Care Health. The oldest executive at Option Care Health, Inc. is John Arlotta, 70, who is the Independent Director.
Richard's mailing address filed with the SEC is C/O OPTION CARE HEALTH, INC., 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN, IL, 60015.
Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten a Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Option Care Health executives and other stock owners filed with the SEC include: